Daily Brief Podcast

In this episode, I explain why some patients do not lose weight right away on GLP 1 medications like Ozempic, Wegovy, Mounjaro, and ZepBound. 

I start with Priscilla, a patient taking 7.5 mg of tirzepatide who lost zero pounds after one month. She was frustrated because someone else on the same medication lost eight pounds in the same amount of time. That comparison is common, but it does not tell the whole story. 

I break down how GLP 1 medications work. These medications help reduce appetite in the brain and help patients feel full sooner by affecting the stomach. But not every body responds the same way. Genetics, receptor differences, diabetes status, sex, environment, eating habits, and daily routines can all influence weight loss. 

I also explain why medication alone is not enough. Successful weight loss usually requires regular follow up, dose adjustments when appropriate, and intensive behavioral changes. Monthly visits matter because they help us review what happened over the previous 30 days, not just what happened yesterday. 

The scale is not a judgment. It is information. It helps us ask better questions. Did your eating pattern change? Were you staying within your calorie goals? Was emotional eating a factor? Did your environment support your weight loss, or work against it? 

This episode is also about physician patient allyship. If you are stalling on Ozempic, Wegovy, Mounjaro, or ZepBound, the answer is not to give up. The answer is to review the dose, the habits, the follow up plan, the support system, and the behavioral changes that make the medication work better. 

The main message is simple: if the scale is not moving, that does not mean you failed. It means we need to look deeper, adjust the plan, and keep working together.

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/

In this episode, I sit down with Dr. Khan to talk about one of the biggest concerns patients have about GLP 1 medications like Ozempic, Wegovy, Mounjaro, and ZepBound: side effects. 

We start with the story of Jaina, a patient who had tried almost everything to lose weight, including South Beach, keto, fasting, and extreme dieting. She was interested in GLP 1 treatment, but she was afraid because of horror stories she had heard about nausea, diarrhea, stomach paralysis, and people getting seriously sick. 

Dr. Khan explains what these medications actually do. GLP 1 medications slow down the digestive system, help food stay in the stomach longer, and make patients feel full sooner. Because they work through the gastrointestinal system, the most common side effects are digestive symptoms like nausea, vomiting, diarrhea, constipation, bloating, cramping, hiccups, burping, and feeling full quickly. 

We also talk about the side effects patients fear most, including gastroparesis and stomach paralysis. These complications can sound frightening, especially when people hear about lawsuits or stories online, but in clinical practice they are very rare. Dr. Khan explains that gastroparesis can also happen because of uncontrolled diabetes itself, and when stomach slowing is related to GLP 1 medications, it is often reversible. 

The key point is that patients should not be left alone to figure this out. GLP 1 medications should be prescribed and monitored by a clinician who understands your medical history, your other medications, your labs, and your side effect risk. Dose increases should be gradual, and if side effects become uncomfortable, your doctor can pause, adjust, or lower the dose. 

We also discuss practical ways to manage common GLP 1 side effects. Mild nausea may improve on its own or with simple options like ginger. If nausea becomes more intense, medication like Zofran may help. Diarrhea can often be managed with Imodium, and constipation may require laxatives or other support. The most important message is to speak up early instead of suffering through symptoms for days. 

Finally, we talk about the benefits many patients forget. GLP 1 medications are known for weight loss, but they may also improve blood sugar, cardiovascular risk, fatty liver disease, kidney health, and sleep apnea. Like every medication, they have risks and benefits. The right approach is not fear. The right approach is informed care, proper monitoring, and a doctor patient relationship that keeps you safe.

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/

In this episode, I explain the connection between depression and weight gain, emotional eating, anxiety, trauma, and obesity. Many patients blame themselves for gaining weight, but weight gain is not always about willpower, diet, or exercise. Sometimes it is a mental health symptom that needs proper care. 

I start with the story of Tommy, a patient who came to me wanting to lose a significant amount of weight through exercise and healthy eating alone. While those lifestyle changes are important, his story reflects a much larger issue in healthcare. Too often, obesity is treated as a simple matter of self control, while the emotional and psychological factors driving weight gain are ignored. 

I discuss how obesity and depression are deeply connected. Studies show that people living with obesity are significantly more likely to struggle with depression, anxiety, and emotional distress. One of the biggest missing pieces in many weight loss conversations is emotional eating, which often becomes the bridge between untreated mental health conditions and excess weight gain. 

In our practice, we take a more comprehensive approach. We use tools like the PHQ 9 and GAD 7 questionnaires to screen for depression and anxiety because understanding a patient’s mental health is often essential to understanding their weight gain. When patients gain large amounts of weight from their baseline, we do not only look at calories and exercise. We also explore stress, trauma, emotional health, relationships, work pressures, and the life events that may be contributing to overeating. 

I also share the story of another patient, Brandon, whose progress changed dramatically after he started working with our psychiatric nurse practitioner and therapist. Once the mental health side of the problem was addressed, his weight loss became more consistent and sustainable. 

This episode is a reminder that obesity is not simply about food. Weight gain can be tied to depression, anxiety, trauma, chronic stress, emotional eating, and untreated mental health conditions. Patients deserve compassionate, evidence based care that looks at the whole person, not just the number on the scale. 

If you recognize these patterns in your own life, talk to your primary care doctor and ask about mental health screening, therapy, or other forms of support. The best long term outcomes often come from combining psychotherapy, lifestyle changes, medical support, and when appropriate, medication.

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/

In this episode, I sit down with pain management specialist Dr. Russ to answer a question patients ask all the time: is this really sciatica, or is it another kind of back pain? 

We start with the story of Tiffany, a patient who developed back pain after moving furniture and assumed it was sciatica because she had looked it up online. But as Dr. Russ explains, not every pain that travels from the back into the buttock or leg is true sciatica. 

True sciatic pain usually comes from irritation of the sciatic nerve. It can feel like shooting pain, burning, tingling, numbness, itching, or an electric shock traveling down the leg. But other problems can mimic sciatica, including disc pain, facet joint pain, piriformis syndrome, and other causes of back or buttock pain. 

Dr. Russ explains how doctors separate these conditions by asking where the pain is, what triggers it, and whether certain movements make it worse, such as bending forward, leaning back, twisting, sitting, or walking. 

We also discuss treatment options, including physical therapy, anti inflammatory medications, Tylenol, ibuprofen, oral steroids, and epidural steroid injections when appropriate. 

Finally, we talk about one of the biggest questions patients have: when do you actually need an MRI? Dr. Russ explains why most patients do not need imaging right away, why conservative treatment often comes first, and when doctors may move from X ray to MRI if symptoms do not improve. 

The main takeaway is simple: before treating sciatica, we first have to confirm that it really is sciatica. 

Topics covered:
Sciatica symptoms
Pinched nerve pain
Back pain vs sciatica
Piriformis syndrome
When to get an MRI
Physical therapy for sciatica
Epidural injections for nerve pain

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/

In this episode, I discuss why GLP 1 medications like Ozempic, Wegovy, Mounjaro, and ZepBound should be treated as science, not opinion. Through Melissa’s story, I explain how some patients are dismissed before they ever get a fair discussion about weight loss treatment. I also break down the evidence behind these medications, the prescribing challenges doctors face, and the access barriers that keep many eligible patients from receiving care. The episode closes with practical advice on how patients can ask better questions, seek second opinions, and find physicians who are prepared to support long term obesity treatment.

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/

In this episode, I talk about what happens when patients are doing the work, making progress, and still run into a healthcare system that makes everything harder than it needs to be. 

I share the story of my patient Patrick, who reached 159 days of sobriety, lost 60 pounds, and was finally building momentum with his health. But then his insurance redirected him into an online weight management program, adding new steps, delays, and impersonal digital interactions that almost made him give up. 

Patrick’s story shows why the physician patient relationship matters so much. Weight loss, sobriety, depression, and long-term behavior change are not solved by willpower alone. Patients need trust, continuity, accountability, and real human support. 

I also discuss why weight loss medications can be an important tool for many patients, and why access barriers can break momentum, reduce adherence, and harm people who are already fighting hard to improve their health. 

This episode is a reminder that patients should not have to navigate confusing systems alone. If your care feels like it is being controlled by policies instead of a clinician who knows you, advocate for yourself, ask questions, and keep fighting for the care you need.

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/

Angela Haynesworth shares her journey of overcoming health challenges post-accident with Dr. Takem's support, highlighting her 88-pound weight loss and the importance of emotional well-being in achieving lasting transformation.

In this episode, I sat down with Angela Haynesworth, and her story is the kind that forces you to rethink what “healing” actually means. Angela takes us back to a moment that changed her identity. After a devastating car accident and the weight gain that followed, she was told she would never run again and would never return to the size she once lived in. For someone who had always been seen as slow—especially in her weight loss journey, quitting would have been easy. This episode is a reminder that healing isn’t only about what you eat. It’s about what you tolerate. Angela didn’t win in a day. She won through years of intentional choices, and her story is proof that you don’t need a miracle. You need a map, and the courage to follow it.

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/

This episode examines GLP-1 medications for obesity, discussing its complexities as a chronic disease. Dr. Khan and the host highlight the need for compassionate, informed care rather than viewing obesity as a personal failure.

In this episode, I dig into a topic I hear about constantly in clinic: GLP-1 medications like Ozempic and Mounjaro, and why there is still so much confusion and judgment around treating obesity. This episode was sparked by a conversation I had with another physician that honestly stopped me in my tracks. They suggested the obesity epidemic could be solved if people just ate better and exercised. That kind of thinking is common, but it is also a major oversimplification, and it ignores what we actually know about obesity as a disease. That moment pushed me to take a deeper look at what is really driving obesity and why medical treatment matters. I am joined by Dr Khan, a primary care physician who speaks directly to this issue. Together, we walk through why obesity is not a character flaw or a simple lifestyle problem. It is a complex, chronic disease shaped by genetics, behavior, nutrition, metabolism, environment, and mental health. Dr Khan explains why blaming individuals is not only inaccurate but also harmful, and why it keeps patients from getting the medicine they need to treat a medical condition. My goal is for clinicians to be allies in this fight, and for patients to feel supported, informed, and taken seriously.

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/

This episode examines weight loss medications, focusing on GLP-1 agonists and Tanika's insurance challenges with Ozempic. It emphasizes the need for patients to understand drug names and advocate for their treatment amidst insurance complexities.

In this episode, we delve into the complexities of weight loss medications, particularly focusing on GLP-1 agonists through the story of a patient named Tanika. After her insurance denied coverage for Ozempic, we unpack the challenges patients face with pharmaceutical names, prescriptions, and insurance nuances. I clarify the differences between GLP-1 agonists like exenatide, liraglutide, semaglutide, and terzepatide, highlighting their unique functions and branding issues related to diabetes versus obesity treatments. We emphasize the importance of correct nomenclature for prescriptions to ensure appropriate insurance approvals and discuss the collaborative effort required between patients and doctors to navigate healthcare obstacles. The episode wraps up with a call to patients to educate themselves and advocate for their needs amidst insurance complexities, ensuring they remain proactive in their treatment journey.

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/

The lecture highlights cardiovascular health and risk factors for heart attacks through Andrew's case. Dr. Hakim stresses the importance of lifestyle changes, early interventions, and patient education to combat heart disease and improve quality of life.

In this episode, I emphasize the critical importance of cardiovascular health and highlight the often overlooked risk factors that can contribute to severe medical events such as heart attacks. Through the case study of Andrew, a patient with multiple chronic conditions, I shed light on the dangers of neglecting routine care and relying on unverified remedies. In this episode, Dr Hakim explains the gradual nature of atherosclerosis and the significance of recognizing undiagnosed coronary artery disease. This episode also covers modifiable risk factors, the impact of systemic inflammation, and the necessity of lifestyle changes to help mitigate heart disease risk. Dr Hakim also advocates for early interventions, patient education, and adherence to prescribed medications, and this episode concludes with a call to prioritize health as essential for a better quality of life

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/